The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents

scientific article

The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1039285893
P356DOI10.1038/ONC.2012.538
P698PubMed publication ID23178489
P5875ResearchGate publication ID233768526

P50authorRobert C BaxterQ41789383
Kamila A MarzecQ85235584
P2093author name stringJ L Martin
M Z Lin
P2860cites workEGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatmentQ24338426
Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cellsQ28139221
Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunitQ28144419
Chromosomal stability and the DNA double-stranded break connectionQ28205315
Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localizationQ28212205
Cellular actions of the insulin-like growth factor binding proteinsQ28216659
Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinaseQ40401323
Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks.Q40464510
Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolaeQ40531770
Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling.Q40568878
Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinasesQ40689818
Regulated migration of epidermal growth factor receptor from caveolaeQ40923075
Insulin-Like Growth Factor Binding Protein Secretion by Breast Carcinoma Cell Lines: Correlation with Estrogen Receptor Status*Q41713966
Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancerQ42439833
IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesityQ43183473
Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulationQ44405114
F-actin-dependent insolubility of chromatin-modifying componentsQ44843426
Insulin-like growth factor binding protein 3 modulates epidermal growth factor (EGF)-induced growth of breast epithelial cells by altering EGF receptor internalizationQ46942900
Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cellsQ47859644
Circulating binding proteins for the insulinlike growth factorsQ47874668
IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)Q56336664
Gene expression correlates of clinical prostate cancer behaviorQ60156349
Lipid Rafts: Membrane Triage CentersQ61040919
Correlation of Insulin-Like Growth Factor-Binding Protein-3 Messenger RNA With Protein Expression in Primary Breast Cancer Tissues: Detection of Higher Levels in Tumors With Poor Prognostic FeaturesQ62267737
Association of insulin-like growth factor binding protein-3 expression with melanoma progressionQ79436245
Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinomaQ80190770
Analysis of the cellular uptake and nuclear delivery of insulin-like growth factor binding protein-3 in human osteosarcoma cellsQ28236310
Cancer-susceptibility genes. Gatekeepers and caretakersQ28236512
Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activityQ28253045
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisQ28258638
IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironmentsQ28270043
Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinomaQ28274499
The DNA-dependent protein kinaseQ28373950
Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinibQ30425201
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.Q33407127
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastomaQ33747609
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry dataQ33779753
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and geneticsQ33801855
DNA double strand break repair and chromosomal translocation: lessons from animal modelsQ34405417
High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranesQ34709520
Nuclear export and mitochondrial and endoplasmic reticulum localization of IGF-binding protein 3 regulate its apoptotic propertiesQ35215665
Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysisQ35872734
Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancerQ36138971
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancerQ36614337
Lipid rafts and membrane trafficQ36768730
Is NHEJ a tumor suppressor or an aging suppressor?Q37140392
Trafficking of receptor tyrosine kinases to the nucleusQ37308472
Tumor suppression by ARF: gatekeeper and caretakerQ37656961
Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and functionQ37676970
Breast cancer statistics, 2011.Q37942073
Links between genome integrity and BRCA1 tumor suppression.Q38029897
Accurate in vitro end joining of a DNA double strand break with partially cohesive 3'-overhangs and 3'-phosphoglycolate termini: effect of Ku on repair fidelityQ38301821
BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrestQ39323364
A requirement for polymerized actin in DNA double-strand break repairQ39333046
Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.Q39416078
DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joiningQ39543261
IGFBP-3 Can Either Inhibit or Enhance EGF-mediated Growth of Breast Epithelial Cells Dependent upon the Presence of FibronectinQ39654146
Effects of endogenous insulin-like growth factor binding protein-3 on cell cycle regulation in breast cancer cells.Q39773767
Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK.Q39940485
Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway.Q40172994
Phosphorylation by DNA-dependent protein kinase is critical for apoptosis induction by insulin-like growth factor binding protein-3.Q40208048
Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis.Q40304159
Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatmentQ40310878
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectbreast cancerQ128581
preproinsulinQ7240673
P304page(s)85-96
P577publication date2012-11-26
P1433published inOncogeneQ1568657
P1476titleThe role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents
P478volume33

Reverse relations

cites work (P2860)
Q92282336Altered blood proteome in girls with high urine concentrations of bisphenol a, genistein, mono-ethyl hexylphthalate and mono-benzyl phthalate
Q92901911Blocking transmembrane219 protein signaling inhibits autophagy and restores normal cell death
Q35236778Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients
Q35123145Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes
Q89861903Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma
Q33866151Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.
Q38893600Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
Q28237971IGF binding proteins in cancer: mechanistic and clinical insights
Q64387949IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer
Q38640378Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.
Q38688202Insider trading: Extracellular matrix proteins and their non-canonical intracellular roles
Q38641329Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies
Q36433403Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Q37004744Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions
Q37688258Insulin-like growth factor binding protein-3 links obesity and breast cancer progression.
Q36413546Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage
Q42600588Involvement of the insulin-like growth factor binding proteins in the cancer cell response to DNA damage
Q54117329Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy.
Q28080513Nuclear actions of insulin-like growth factor binding protein-3
Q92729642Paracrine senescence of human endometrial mesenchymal stem cells: a role for the insulin-like growth factor binding protein 3
Q42364417Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines
Q97546454RNA-binding proteins in tumor progression
Q47435335Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells
Q26801886Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast Cancer
Q92642332Therapeutic Targeting of the IGF Axis
Q26798408Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment

Search more.